Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

This study has been completed.

Study NCT00229697 Information provided by AstraZeneca

First Received: September 28, 2005 Last Updated: June 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2006
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)